Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer
Clinical trial NCT03358017 · COMPLETED
Trial details
- NCT number
- NCT03358017
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2021-06-17
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.